DFDA

Methyldopa

Treatment for Maternal Hypertensive Disorders

Typical Dosage: 250-500 mg 2-4 times daily

Effectiveness
82%
Safety Score
69%
Clinical Trials
100
Participants
3K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
69
DangerousModerateSafe
Treatment Details
Dosage Range
250-500 mg 2-4 times daily
Time to Effect
2-6 hours (oral)
Treatment Duration
Until delivery
Evidence Quality
HIGH
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$1,000
Side Effect Mgmt:$250
Total Annual:$1,300
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.25
Outcome-Based Costs
Cost per Responder
$1,625
Prescription Access Economics
Physician Visit Cost
$1,000/year
Time Cost
$240/year
Travel + wait time
Insurance Admin Cost
$240/year
Prior auth, claims
Rx Price
$50/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
LOW
Requires Monitoring
Yes
Needs lab work/checkups
Methyldopa Outcomes

for Maternal Hypertensive Disorders

Efficacy Outcomes
Overall Effectiveness
+82%
Response Rate
+80%
Common Side Effects
Drowsiness
+25%
Dry mouth
+12%
Headache
+8%
Dizziness
+8%

Sources:

researchgate.net
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov